AMGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Amgen Inc's quarterly cash and cash equivalents declined from Sep. 2013 ($8,281 Mil) to Dec. 2013 ($3,805 Mil) and declined from Dec. 2013 ($3,805 Mil) to Mar. 2014 ($3,687 Mil).
Amgen Inc's annual cash and cash equivalents declined from Dec. 2011 ($6,946 Mil) to Dec. 2012 ($3,257 Mil) but then increased from Dec. 2012 ($3,257 Mil) to Dec. 2013 ($3,805 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Amgen Inc Annual Data
Amgen Inc Quarterly Data